This federal contract award, valued at $27,923.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a medical product, with a completion date of November 15, 2024. This is a Firm Fixed Price Delivery Order contract, and it does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/13/25, 9:31 AM